Login
$CRDF
$0.91 +$0.18 (24.97%) Live

$CRDF 8-K/A SEC Filings

Filed On Filing
14 Jun 2022 8-K/A: Submission of Matters to a Vote of Security Holders

On June 9, 2022, Cardiff Oncology, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). A total of 29,365,861 shares of common stock, constituting a quorum, were represented in person or by valid proxies a...

17 Jun 2020 8-K/A: Other Events

On June 16, 2020, the Company issued a press release announcing it has entered into a securities purchase agreement, jointly led by biotech-focused fundamental institutional investors, Acorn Bioventures and CAM Capital, at the closing pr...

23 Jun 2017 8-K/A: Submission of Matters to a Vote of Security Holders

Proposal 3. The adoption of an amendment to the Company’s 2014 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder to 9,500,000 from 7,500,000 was approved by the stockholders by the vo...

11 Mar 2016 8-K/A: Results of Operations and Financial Condition

In the news release, Trovagene Announces Fourth Quarter and Year End 2015 Financial Results, issued 10-Mar-2016 by Trovagene, Inc. over PR Newswire, we are advised by the company that in the Condensed Consolidated Statements of Operation...

13 Jan 2016 8-K/A: Other Events

Forward-Looking Statements Statements in this presentation about the Company's expectations, applications of its technology, markets, launch of tests and other statements that are not historical facts are “forward-looking statements” wit...

27 Jun 2013 8-K/A: Financial Statements and Exhibits

A better clinical pathway for cancer monitoring Antonius Schuh, Ph.D. | Chief Executive Officer June 2013

22 Jul 2005 8-K/A: Unregistered Sales of Equity Securities

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY APPLICABLE STATE SECURITIES OR “BLUE SKY” LAWS. THESE SECURITI...

15 Sep 2004 8-K/A: Financial Statements and Exhibits

Audited Balance Sheet of Xenomics as of July 31, 2003 and 2002 and the related Statements of Operations, Stockholders' Equity (Deficit) and Cash Flows for the years then ended and cumulatively from inception August 4, 1999 to July 31, 2003.

28 Jul 2004 8-K/A: Changes in Control of Registrant; Completion of Acquisition or Disposition of Assets +1 more

This memorandum provides certain information about Xenomics, Inc. (the "Company") as of the above date. It is not intended as an offer to sell any securities of the Company, nor as a solicitation of an offer to buy such securities, nor d...

12 Mar 2004 8-K/A: Changes in Control of Registrant

CAPITAL STOCK PURCHASE AGREEMENT, dated February 24, 2004, by and between Jeannine Karklins, the principal shareholder ("Shareholder") of Used Kar Parts, Inc., a Florida corporation, (the "Company") maintaining a mailing address at 20908...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support